The role of PIK3CA mutations was also demonstrated in CRC by showing inhibition of growth in PIK3CA mutant CRC cell lines by treatment with LY294002 (Samuels et al., 2005). The gene discussed is PIK3CA; the disease is colorectal carcinoma.